Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Whole transcriptome sequencing of peripheral blood from opioid use disorder

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE198123 | GEO | 2022/05/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Whole transcriptome sequencing of peripheral blood from opioid use disorder [miRNA-seq]

Project description:7 male OUD patients and 7 male health controls with demographic and clinical data matched were enrolled in this study. rRNA removed library and small RNA library were constructed using peripheral blood RNA. RNA-seq was used to investigate the peripheral transcriptomic changes between the two groups.

2022-05-31 | GSE198122 | GEO

Whole transcriptome sequencing of peripheral blood from opioid use disorder [RNA-seq]

2022-05-31 | GSE198121 | GEO

Whole transcriptome sequencing of peripheral blood from opioid use disorder

Project description:Whole transcriptome sequencing of peripheral blood from opioid use disorder

| PRJNA813839 | ENA

Whole Transcriptome Sequencing of Peripheral Blood Shows That Immunity/GnRH/PI3K-Akt Pathways Are Associated With Opioid Use Disorder.

Project description:BackgroundOpioid use disorder (OUD), which is most commonly exhibited as addiction, is a persistent chronic disease that places a burden on families and society. Various peripheral traits have been linked to OUD in the past, but research on this topic is insufficient.MethodsSeven male patients with OUD and 7 male healthy controls with matched demographic and clinical data were enrolled in this study. Peripheral blood RNA was used to construct an rRNA-removed library and a small RNA library. The peripheral transcriptomic differences between the two groups were investigated using RNA-seq. Differentially expressed messenger RNAs (mRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs) and microRNAs (miRNAs) were identified by bioinformatics methods, and functional enrichment analysis with differentially expressed RNAs was performed to investigate the potential biological mechanisms of OUD.ResultsA total of 229 mRNAs (115 upregulated, 114 downregulated), 416 lncRNAs (191 upregulated, 225 downregulated), 17 circRNAs (16 upregulated, 1 downregulated) and 74 miRNAs (42 upregulated, 32 downregulated) were differentially expressed between the OUD group and the healthy control group. Functional enrichment analysis with differentially expressed mRNAs showed that immunity, GnRH secretion, and PI3K-Akt signaling pathways were associated with OUD. Immunity-, JAK-STAT-, and insulin-related pathways were enriched in functional enrichment analysis of target genes predicted by differentially expressed miRNAs.ConclusionWe identified hundreds of differentially expressed genes that were enriched in immunity, GnRH secretion and PI3K-Akt signaling pathways. Some genes with significant changes might be used as potential biomarkers for progression and treatment of OUD.

| S-EPMC9253397 | biostudies-literature

Whole transcriptome sequencing of peripheral blood from opioid use disorder [miRNA-seq]

Project description:Whole transcriptome sequencing of peripheral blood from opioid use disorder [miRNA-seq]

| PRJNA813953 | ENA

Whole transcriptome sequencing of peripheral blood from opioid use disorder [RNA-seq]

Project description:Whole transcriptome sequencing of peripheral blood from opioid use disorder [RNA-seq]

| PRJNA813954 | ENA

Globin mRNA reduction for whole-blood transcriptome sequencing.

Project description:The transcriptome analysis of whole-blood RNA by sequencing holds promise for the identification and tracking of biomarkers; however, the high globin mRNA (gmRNA) content of erythrocytes hampers whole-blood and buffy coat analyses. We introduce a novel gmRNA locking assay (GlobinLock, GL) as a robust and simple gmRNA reduction tool to preserve RNA quality, save time and cost. GL consists of a pair of gmRNA-specific oligonucleotides in RNA initial denaturation buffer that is effective immediately after RNA denaturation and adds only ten minutes of incubation to the whole cDNA synthesis procedure when compared to non-blood RNA analysis. We show that GL is fully effective not only for human samples but also for mouse and rat, and so far incompletely studied cow, dog and zebrafish.

| S-EPMC4981843 | biostudies-literature

Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood

Project description:This SuperSeries is composed of the SubSeries listed below.

2010-05-13 | GSE19833 | GEO

Peripheral blood microRNA levels in females with cocaine use disorder.

Project description:BACKGROUND:There is growing emphasis in the field of psychiatry on the need to identify candidate biomarkers to aid in diagnosis and clinical management of addictive disorders. MicroRNAs (miRNAs) are small nucleotide sequences with the ability to regulate gene expression at the transcriptomic level. However, the role of miRNAs as potential biomarkers for addiction is still underexplored. Based on translational and clinical findings, we compared the expression levels of microRNA-124 (miR-124), microRNA-181 (miR-181), and microRNA-212 (miR-212) between a group of females with cocaine use disorder (CUD; n?=?30) and a group of healthy female controls (HC; n?=?20). METHODS:Blood expression levels of miR-124, miR-181, and miR-212 in the HC and CUD group were determined by qPCR, using two miRNAs as endogenous controls (miR-24 and miR-126). Substance use behavior was assessed by self-report using the Addiction Severity Index (ASI-6) and depressive symptoms severity was measured using the Beck Depressive Inventory (BDI-II). Urine screen test was performed to detect cocaine metabolites. RESULTS:Mir-124 and miR-181 were upregulated in the CUD group (p?>?0.01). Furthermore, increased cognitive/affective depression symptoms were identified among a CUD subgroup with the higher miR-181 expression levels (p?>?0.05). No significant difference in expression levels was found for miR-212. CONCLUSIONS:MiR-124 and miR-181 show promise as biomarkers for CUD when assessed in the peripheral blood. Further investigation is needed to elucidate the molecular mechanisms underlying these associations and to validate target genes regulated by these miRNAs.

| S-EPMC6546503 | biostudies-literature

Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-08-30 | GSE230096 | GEO